Career

Dr Etemad-Sajadi has performed his neurosurgical training in Lausanne, under the supervision of Prof. Villemure, as well as in Montreal. During his clinical training, Dr Etemad-Sajadi had the opportunity to practice and acquire extensive experience in dealing with various spinal and cerebral pathologies. These included upper and lower spinal disc herniation, spinal canal stenosis, as well as more complicated surgical procedures, such as stabilization of the spinal column. Dr Etemad-Sajadi has also a solid experience in the treatment of oncological disorders, such as brain and spinal tumours, as well as the treatment of hydrocephalus.

Dr. Etemad-Sajadi is a member of several medical societies, including the Swiss Society of Neurosurgery (SSNC) and the Swiss Society of Spinal Surgery (SGC).

During the early years of his training, Dr Etemad-Sajadi had the opportunity to lead a research project in EPFL on gene therapy for Parkinson’s disease, under Prof. Patrick Aebischer’s direction. This project led to a M.D.-Ph.D. diploma in Neurosciences.

Areas of interest

• Spinal surgery
• Surgery of brain tumours
• Surgery for hydrocephalus

Diploma

• M.D. : Medical school, Lausanne University, Switzerland.
• Ph.D. in Neurosciences : EPFL (Ecole Polytechnique Fédérale de Lausanne), Switzerland.
• FMH : Swiss and European board of speciality in Neurosurgery.
• Fellowship in Pediatric Neurosurgery in St-Justine Hospital, Montreal University.

Publications

Fulminant Meningoencephalitis as the First Clinical Sign of an Invasive Pituitary Macroadenoma.
Case Rep Neurol. 2010 Nov 3;2(3):133-138.
Robert T, Sajadi A, Uské A, Levivier M, Bloch J.

Hemorrhagic strokes in children: etiology and management.
Rev Med Suisse. 2010 Feb 24;6(237):401-4, 406-7. French.
El Hassani Y, De Ribaupierre S, Sajadi A, Pereira VM, Rilliet B.

Pilomyxoid astrocytoma of the spinal cord in an adult.
Acta Neurochir (Wien). 2008 Jul;150(7).
Sajadi A, Janzer RC, Lu TL, Duff JM.

An unusual case of metastatic melanoma sensitive to chemotherapy and immunotherapy, with late immune escape in the brain.
Cancer Immun. 2008 Mar 27;8:6.
Voelter V, Pica A, Laurent J, Rimoldi D, Bouzourene H, Sajadi A, Matter M, Romero P, Rufer N, Speiser DE.

Neuronal death and growth factors: new therapeutic approaches in Parkinson's disease.
Rev Med Suisse 2006 May 3;2(64).
Wider C, Burkhard PR, Sajadi A, Vingerhoets FJG.

Transient striatal delivery of GDNF via encapsulated cells leads to sustained behavioral improvement in a bilateral model of Parkinson disease.
Neurobiol Dis. 2005 Nov 18.
Sajadi A, Bensadoun JC, Schneider BL, Lo Bianco C, Aebischer P.

Long-term glial cell line-derived neurotrophic factor overexpression in the intact nigrostriatal system in rats leads to a decrease of dopamine and increase of tetrahydrobiopterin production.
Journal of Neurochemistry 2005 Jun;93(6).
Sajadi A, Bauer M, Thöny B and Aebischer P.

Wlds-mediated protection of dopaminergic fibers in an animal model of Parkinson disease.
Current Biology 2004 Feb 17;14(4).
Sajadi A, Schneider BL, Aebischer P.
A press release was made on this article in february 2004 and it was quoted in the "Science" journal :
Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration.
Science. 2004 Aug 13;305(5686):1010-3.

Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease.
Proc Natl Acad Sci USA. 2004 Dec 14;101(50).
Lo Bianco C, Schneider BL, Bauer M, Sajadi A, Brice A, Iwatsubo T, Aebischer P.

Spinal tumors: clinical aspects, classification and surgical treatment.
Schweiz Rundsch Med Prax. 2003 Nov 5;92(45). Review.
Porchet F, Sajadi A, Villemure JG.

Unusual locations of hemangioblastomas. Case illustration.
J Neurosurg. 2002 Sep;97(3).
Sajadi A, de Tribolet N.